Moderna COVID-19 Vaccines Prioritized
Last Updated on 2 years by Publishing Team
18 July 2021
Moderna COVID-19 Vaccines Prioritized for Pregnant Women in High-Risk Areas
Beginning Wednesday, 21 July 2021, the Ministry of Health and Medical Services will administer the Moderna COVID-19 vaccines to pregnant women across Viti Levu.
Due to the increasing widespread transmission of COVID-19 disease across Viti Levu, pregnant women are at a higher risk of contracting the virus which may cause severe illness.
As a result, these women are prioritized for receiving the Moderna vaccines that provide earlier protection against the disease due to its shorter interval period of 28 days between the first and the second dose.
Pregnant women who are employed as civil servants and are waiting to receive their COVID-19 vaccines, may continue to go to work as they will be temporarily exempted until August 1st 2021.
For vaccination, pregnant women must provide their antenatal care clinic card as an evidence of pregnancy and booking done with the Ministry of Health and Medical Services.
The Ministry of Health recommends that pregnant women living outside Viti Levu must continue to receive the AstraZeneca COVID-19 vaccines.
Additionally, Fiji has recorded high number of deaths of individuals aged 60 years and above, particularly those with comorbidity issues as a result of severe illness from COVID-19. These deaths were mainly recorded within the Suva-Nausori corridor where the transmission is widespread.
Therefore, to provide earlier protection to the remaining unvaccinated vulnerable group within the Suva-Nausori corridor, the Moderna vaccines will be administered to individuals above 60 years of age residing in Suva-Nausori corridor, particularly those with comorbidities such as chronic lung disease, significant cardiac disease, severe obesity, diabetes, liver disease and human immunodeficiency virus (HIV) infection.
Further information in relation to the roll out of the Moderna vaccine will be provided by the Ministry of Health soon.